frovatriptan has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, JC; Hu, X; MacGregor, EA; Pawsey, SP | 1 |
| Adelman, JU; Lewit, EJ | 1 |
2 review(s) available for frovatriptan and Cardiovascular Diseases
| Article | Year |
|---|---|
Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
Topics: Acute Disease; Carbazoles; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Safety; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2010 |
Comparative aspects of triptans in treating migraine.
Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2001 |